| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/02/2009 | US20090087420 Stable solution of reduced coenzyme q |
| 04/02/2009 | US20090087408 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 04/02/2009 | US20090087406 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 04/02/2009 | US20090087389 Dehydroepiandrosterone sulfate dihydrate inhalation compositions and methods |
| 04/02/2009 | US20090087380 Polymer devices for therapeutic applications |
| 04/02/2009 | US20090087377 Compositions for targeted imaging and therapy |
| 04/02/2009 | DE102007045066A1 Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide Material for hemostasis containing synthetic peptides or polysaccharides |
| 04/02/2009 | CA2701032A1 Pharmaceutical formulations |
| 04/02/2009 | CA2700983A1 Composition and method of stabilized sensitive ingredient |
| 04/02/2009 | CA2700808A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | CA2700587A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 04/02/2009 | CA2700480A1 Orally-administered agent |
| 04/02/2009 | CA2698827A1 Makeup-assisting patch and makeup method using the patch |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042195A1 Polymer conjugate of combretastatin |
| 04/01/2009 | EP2042184A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle |
| 04/01/2009 | EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 04/01/2009 | EP2042180A1 Preparations containing phytosterol |
| 04/01/2009 | EP2042174A1 Adhesive preparation |
| 04/01/2009 | EP2042164A1 Stabilized solid preparation |
| 04/01/2009 | EP2042163A1 Pharmaceutical compositions comprising fluvastatin |
| 04/01/2009 | EP2041167A1 Derivatisation of granulocyte colony-stimulating factor |
| 04/01/2009 | EP2040758A2 Bioresponsive polymers |
| 04/01/2009 | EP2040757A2 New protein conjugates and methods for their preparation |
| 04/01/2009 | EP2040756A1 Composition containing metal-acidic amino acid chelate accelerating absorption of metal |
| 04/01/2009 | EP2040736A1 New formulation for increasing bioavailability of neurturin |
| 04/01/2009 | EP2040699A2 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 04/01/2009 | EP2040693A2 Transdermal delivery of oleocanthal for relief of inflammation |
| 04/01/2009 | EP2040691A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 04/01/2009 | EP2040687A1 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine |
| 04/01/2009 | EP2040678A2 Improvements relating to biocidal compositions |
| 04/01/2009 | EP2040541A1 Adjuvants and methods of use |
| 04/01/2009 | EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/01/2009 | EP1572241B1 Oral pharmaceutical compositions comprising cyclosporin |
| 04/01/2009 | EP1467720B1 Dna dosage forms |
| 04/01/2009 | EP1458388B1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 04/01/2009 | EP1450804B9 Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | EP1368486A4 Formulations for il-11 |
| 04/01/2009 | EP1126828B1 Oral administration of adenosine analogs |
| 04/01/2009 | EP1123087B1 Oral pulsed dose drug delivery system |
| 04/01/2009 | EP1014941B1 Hot-melt extrudable pharmaceutical formulation |
| 04/01/2009 | EP0906243B2 Dissolvable oxides for biological applications |
| 04/01/2009 | CN101400670A Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/01/2009 | CN101400371A Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 04/01/2009 | CN101400364A Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 04/01/2009 | CN101400354A Aqueous composition |
| 04/01/2009 | CN101400351A Medicament formulations comprising fluoroquinolones |
| 04/01/2009 | CN101400343A Modified release formulations containing drug-ion exchange resin complexes |
| 04/01/2009 | CN101400339A Formulations of sitaxsentan sodium |
| 04/01/2009 | CN101400335A Central administration of stable formulations of therapeutic agents for CNS conditions |
| 04/01/2009 | CN101397367A Collagen molecule fragment grafted aliphatic polyester binary or terpolymer, preparation method and use |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 04/01/2009 | CN101396563A Chitose derivates using octreotide as target ligand and use thereof in medicament |
| 04/01/2009 | CN101396558A Medicinal preparation for treating rhinitis and sinusitis |
| 04/01/2009 | CN101396553A Recombined human blood vessel endothelial inhibin sustained-release injection composition |
| 04/01/2009 | CN101396437A Anti-gout drop pills of pure traditional Chinese medicine |
| 04/01/2009 | CN101396431A Bitongning gel and its preparing method |
| 04/01/2009 | CN101396377A Moisture protection method of traditional Chinese medicine extract |
| 04/01/2009 | CN101396370A Medicine composition for treating mouth, throat disease and preparation method thereof |
| 04/01/2009 | CN101396366A Solid oral preparation containing valsartan and preparation method thereof |
| 04/01/2009 | CN101396354A Stable taxabe compound liquid combination and preparation method and use thereof |
| 04/01/2009 | CN101396351A Drug-loaded polyelectrolyte capsules in response to phosphatase concentration and preparation method thereof |
| 04/01/2009 | CN101396350A Clopidogrel hydrogen sulfate dispersible tablets and preparation method thereof |
| 04/01/2009 | CN101396348A Omeprazole enteric-coated micro-pill |
| 04/01/2009 | CN101396346A Paclitaxel lipid composite |
| 04/01/2009 | CN101396344A Paeonol microemulsion preparation and preparation method thereof |
| 04/01/2009 | CN101396342A Anti-cancer sustained-released injection containing epothilone derivate |
| 04/01/2009 | CN101396341A Anti-cancer sustained-released agent |
| 04/01/2009 | CN101396340A Anti-cancer sustained-released injection containing epothilone derivate |
| 04/01/2009 | CN101396339A Novel degradable lacrimal passage plug and preparation method thereof |
| 04/01/2009 | CN101396338A Sustained-release injection containing methotrexate and synergist thereof |
| 04/01/2009 | CN101396337A Paclitaxel loaded sustained release nano fiber and preparation method and use thereof |
| 04/01/2009 | CN101396333A Eye in-situ gel of chiral anti-glaucoma medicine L-3alpha alkyla acyloxy-6belta alkyla acyloxy tropane and preparation method thereof |
| 04/01/2009 | CN100473385C Process for dissolving 3,5-substituted oxazolidone |
| 04/01/2009 | CN100473384C Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | CN100473382C Oral dosage form for propiverine or pharmaceutically acceptable salts thereof with an extended release of the active ingredient |
| 04/01/2009 | CN100473377C Process for producing soft gelatin capsule |
| 04/01/2009 | CN100473376C Stabilized aqueous suspensions for parenteral administration |
| 04/01/2009 | CN100473291C Food or pet food composition containing plant extract for bone health |
| 03/31/2009 | US7511173 Nutrient, foods; dietary supplements, energy drinks, and dietetic or pharmaceutical products; creatine glycinate |
| 03/31/2009 | US7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 03/31/2009 | US7511094 2-methylbutyraldehyde diethyl acetal end capped polyoxyethylene glycol; polyalkylene oxide, polyivnylpyrrolidone, polyvinyl alcohol, polyoxazoline etc. endcapped with polyetherpolyamine copolymers or oligomers covalently attached to diacetal tetramethylene group |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511023 adriamycin; chemotherapy; sustained release |
| 03/31/2009 | US7511014 Cyclosporin active, fatty acid triglyceride, glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10; immunosuppressant, anti inflammatory, anti parasitic |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7511010 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510731 Water-soluble stabilized self-assembled polyelectrolytes |
| 03/31/2009 | US7510727 Unit dose sustained-release oral dosage form of melt extruded particles of specified particle size comprising a drug such as an opiod, one or more retardants, and an optional water insoluble binder |
| 03/31/2009 | US7510721 Multi-purpose acid compositions |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | US7510698 Adjuvant formulation consisting essentially of a metabolizable oil and alpha tocopherol in emulsion for enhancing immune response to infection |
| 03/31/2009 | US7510556 Vessel sealing instrument |